Market Research Reports, Inc. has announced the addition of “US Market Report for Erectile Dysfunction Devices 2016 - MedCore” research report to their website www.MarketResearchReports.com

Lewes, DE -- (SBWire) -- 08/17/2016 --For an erection to occur, blood flows into the penis, causing it to expand and stiffen, which is sparked by impulses from the brain to the genital nerves. ED can be caused when these impulses are blocked or the flow of blood to the penis is restricted. Chronic diseases such as diabetes, cardiovascular disease, atherosclerosis, kidney disease and multiple sclerosis can be common underlying causes. Certain medications, psychological factors and injuries could also be factors leading to ED.

Treatments for ED include medications, lifestyle changes, injections, surgeries and devices. Common medications prescribed for ED include sildenafil (Viagra®), tadalafil (Cialis®), vardenafil hydrochloride (Levitra®) and avanafil (StendraTM), which are taken orally prior to intercourse. This group of medications, called phosphodiesterase type 5 (PDE-5) inhibitors, increase the flow of blood to the penis. It can be dangerous for men to take PDE-5 concurrently with nitrate drugs for heart disease or alpha-blockers for benign prostate hyperplasia (BPH). There is a 50% success rate using drug therapy; the remaining 50% of unsuccessful patients may opt to get vasodilators injected into the penis. Other options for when drug therapy options fail include the use of a vacuum device or penile implant surgeries. While the condition is quite common, only approximately 20% of men who experience ED will seek treatment.

ED implantation procedures are performed in outpatient offices and are completed in 1 or 2 hours. Vacuum constriction devices are external devices that use a constriction band or ring to help maintain an erection. They can be preferred over implantation procedures as they are non-invasive.

Erectile dysfunction (ED) can be described as the frequent inability for a man to attain and sustain an erection; this could inhibit sexual intercourse and affect quality of life. Onset of ED can begin at the age of 40 and affects 18 to 30 million men. Occasional failure to achieve an erection is not uncommon but a prevalence of 50% or more of the time could be an indication that treatment is required. ED tends to increase with age but treatment can be sought at any age.

Spanning over 49 pages "US Market Report for Erectile Dysfunction Devices 2016 - MedCore" report covers Executive Summary, Research Methodology, Erectile Dysfunction Device Market. The report covered companies are - Boston Scientific, Coloplast, Augusta Medical Systems, Owen Mumford, UroMatrix

For more information Visit at: http://www.marketresearchreports.com/idata-research/us-market-report-erectile-dysfunction-devices-2016-medcore

Find all Medical Devices Reports at: http://www.marketresearchreports.com/medical-devices

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

Yearly/Quarterly Report Subscription: http://www.marketresearchreports.com/subscriptions